A detailed history of Stoneridge Investment Partners LLC transactions in Chimerix Inc stock. As of the latest transaction made, Stoneridge Investment Partners LLC holds 36,171 shares of CMRX stock, worth $31,830. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,171
Previous 36,171 -0.0%
Holding current value
$31,830
Previous $32,000 6.25%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$0.91 - $1.26 $32,915 - $45,575
36,171 New
36,171 $38,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Stoneridge Investment Partners LLC Portfolio

Follow Stoneridge Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stoneridge Investment Partners LLC with notifications on news.